Wednesday October 29th

The Norwegian Inflammation Network (NORIN) seminar

The Norwegian Inflammation Network (NORIN) is holding a seminar on Wednesday, 29 October entitled “Sufficient options to treat inflammation? Looking at the pipeline of the pharmaceutical industry.”


Register by October 24th.

Norwegian Inflammation Network

Wednesday 29 October 2014 at 15:00, Domus Medica, "Rotunde," Runde auditorium (GA21 R-105), Sognvannsveien 9, University of Oslo

"Sufficient options to treat inflammation? Looking at the pipeline of the pharmaceutical industry"

15:00-15:10Introduction

15:10-15:40

Tore Kvien, University of Oslo/Diakonhjemmet Hospital
"What has been achieved with new drugs and treatment strategies and which gaps need to be addressed in the future management of inflammatory rheumatic diseases?"

15:40-16:10

Jon Florholmen, University Hospital of North Norway
"Challenges in biological treatment of inflammatory bowel disease"
16:10-16:40

Coffee break

16:40-17:00

Alexandre Corthay, University of Oslo/Oslo University Hospital
"Introduction to pipeline targets"

17:00-17:20

Loredana Regep, Medical Director, Roche
"The research for future treatment of inflammatory diseases"

17:20-17:40

Erik Hjelvin, Medical Director, Pfizer
"Inflammation targets from the Pfizer perspective"

17:40-18:00

Steinar Thoresen, Medical Director, Abbvie
"Inflammation, Immunology and Cancer: what is seen on the horizon?"

18:00- 20:00

NETWORKING WITH TAPAS AND WINE

Download program in PDF format

Register by 24 October: https://nettskjema.uio.no/answer/61387.html